R E Ferner
- Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes 27
- Toxicology top 0.1%
- Pharmacovigilance and Adverse Drug Reactions 48
- Emergency Medical Services top 0.2%
- Patient Safety and Medication Errors 20
- Family Practice top 1%
-
- Pharmaceutical studies and practices 34
-
- Pharmaceutical Economics and Policy 22
- Health Systems, Economic Evaluations, Quality of Life 15
-
- Poisoning and overdose treatments 20
-
- Drug-Induced Adverse Reactions 12
- Co-authors
- Jeffrey K AronsonSarah McDowellJamie J. ColemanAnthony CoxSally BradberryJ. Mark WilkinsonH. A. W. NeilD. Nicholas Bateman
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
R E Ferner
213 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 193
- Geriatrics and Gerontology 844
- Toxicology 724
- Emergency Medical Services 624
- Family Practice 156
- Medical Laboratory Technology 100
Countries citing papers authored by R E Ferner
This map shows the geographic impact of R E Ferner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Ferner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Ferner more than expected).
Fields of papers citing papers by R E Ferner
This network shows the impact of papers produced by R E Ferner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Ferner. The network helps show where R E Ferner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R E Ferner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 8 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2019 | 58 | |
| 13 | 2019 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2019 | 8 | |
| 16 | 2019 | 22 | |
| 17 | 2017 | 58 | |
| 18 | 2008 | 4 | |
| 19 | A fruitful idea | 2005 | 2 |
| 20 | Increase in US medication-error death (Letter comment) | 1998 | 1 |
About R E Ferner
R E Ferner is a scholar working on Toxicology, Medical Terminology and Geriatrics and Gerontology, having authored 223 papers that have together received 4.9k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (48 papers), Pharmaceutical studies and practices (34 papers), Pharmaceutical Practices and Patient Outcomes (27 papers), Pharmaceutical Economics and Policy (22 papers), Poisoning and overdose treatments (20 papers), Patient Safety and Medication Errors (20 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Drug-Induced Adverse Reactions (12 papers). The work is most often cited by research in Geriatrics and Gerontology (844 citations), Toxicology (724 citations) and Emergency Medical Services (624 citations). R E Ferner has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Jeffrey K Aronson, Sarah McDowell, Jamie J. Coleman, Anthony Cox, Sally Bradberry, J. Mark Wilkinson, H. A. W. Neil, D. Nicholas Bateman, J K Aronson and M. D. Rawlins. Their work appears in journals such as British Journal of Clinical Pharmacology, Drug Safety, BMJ, Journal of the Royal Society of Medicine and Clinical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.